or Try an Advanced Search...

    Technical Analysis for FTRE - Fortrea Holdings Inc.

    Grade Last Price % Change Price Change
    D 19.73 1.18% 0.23
    FTRE closed up 1.18 percent on Friday, November 22, 2024, on 57 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical FTRE trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    Multiple of Ten Bearish Other 0.00%
    Wide Bands Range Expansion 0.00%
    Up 3 Days in a Row Strength 0.00%
    50 DMA Resistance Bearish 1.18%
    20 DMA Support Bullish 1.18%
    Wide Bands Range Expansion 1.18%
    Crossed Above 20 DMA Bullish 3.03%
    Wide Bands Range Expansion 3.03%
    Fell Below 20 DMA Bearish 5.62%
    Older End-of-Day Signals for FTRE ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance 1 day ago
    Up 3% 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    Rose Above Previous Day's High 1 day ago
    Up 2% 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    FTRE Chart by TradingView
    Basic chart:

    Profile

    Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Clinical Research Clinical Pharmacology Contract Research Organizations Patient Access Solutions

    Is FTRE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Keith Meister's Corvex opens fresh stakes in Dollar Tree, APD, exits CAE: top Q3 trades
    Nov 12 US$24.56 - That's What Analysts Think Fortrea Holdings Inc. (NASDAQ:FTRE) Is Worth After These Results
    Nov 12 Fortrea price target raised to $30 from $28 at Baird
    Nov 10 Fortrea Holdings Third Quarter 2024 Earnings: EPS Beats Expectations
    Nov 9 Fortrea Holdings Inc (FTRE) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing ...
    Nov 8 Fortrea Holdings, Inc. (FTRE) Q3 2024 Earnings Call Transcript
    Nov 8 Fortrea Stock Explodes 37%--Investors Are Eyeing Massive Gains
    Nov 8 Fortrea Holdings Inc. 2024 Q3 - Results - Earnings Call Presentation
    Nov 8 Fortrea Holdings Non-GAAP EPS of $0.23, revenue of $674.9M
    Nov 8 Fortrea Reports Third Quarter 2024 Results
    See more FTRE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 41.02
    52 Week Low 16.53
    Average Volume 1,624,113
    200-Day Moving Average 27.31
    50-Day Moving Average 19.53
    20-Day Moving Average 19.06
    10-Day Moving Average 20.14
    Average True Range 1.25
    RSI (14) 51.92
    ADX 21.93
    +DI 31.82
    -DI 23.25
    Chandelier Exit (Long, 3 ATRs) 21.54
    Chandelier Exit (Short, 3 ATRs) 20.27
    Upper Bollinger Bands 22.98
    Lower Bollinger Band 15.14
    Percent B (%b) 0.59
    BandWidth 41.13
    MACD Line 0.14
    MACD Signal Line 0.12
    MACD Histogram 0.0152
    Fundamentals Value
    Market Cap 1.75 Billion
    Num Shares 88.8 Million
    EPS 0.06
    Price-to-Earnings (P/E) Ratio 328.83
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 21.17
    Resistance 3 (R3) 21.15 20.64 20.93
    Resistance 2 (R2) 20.64 20.28 20.66 20.85
    Resistance 1 (R1) 20.19 20.05 20.42 20.21 20.77
    Pivot Point 19.68 19.68 19.80 19.70 19.68
    Support 1 (S1) 19.23 19.32 19.46 19.25 18.69
    Support 2 (S2) 18.72 19.09 18.74 18.61
    Support 3 (S3) 18.27 18.72 18.53
    Support 4 (S4) 18.29